Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Developing therapeutics to treat human diseases and improve global health

Diseases disrupt our lives. We’re innovating technologies to deliver superior treatments for diseases.

One of the greatest challenges we face in global health is the increasing speed and spread of diseases. We want to enable people to be well and live life to the fullest.

Infectious and other diseases present a significant and growing risk to global public health. Access to effective and safe treatments is essential in our efforts to combat these challenges and protect communities worldwide.

Our innovative platform shows promise for targeted, effective therapeutics for human diseases

A streamlined approach

Our platform employs unique approaches to accelerate drug development and further prevent spread of diseases.

Combinatorial Strategy

We combine CRISPR systems to directly target the site of replication or cellular mechanisms.

Multiplex Approach

We multiplex highly-specific CRISPR guides to target conserved locations within pathogenic genomes.

Translational Biology

Our target ablation platform limits disease progression, enabling the host organism to mount protective responses to better fight disease.

Diseases disrupt communities and strain healthcare systems; we want to change that.

Back to top Drag